Clinical Trial Update: Pharmacokinetic Study of Extended Infusion Meropenem in Adult Cystic Fibrosis Patients [NA]

View source ↗

Summary

Clinical trial update describing a pharmacokinetic study of extended-infusion meropenem in adults with cystic fibrosis, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Meropenem (Meropenem)

Snippet

Sponsor: Unity Health Toronto | Conditions: Cystic Fibrosis Pulmonary Exacerbation | NA | Status: TERMINATED